Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dia-Foot is a specialized medical device and healthcare services company focused on the diabetic foot care market. Founded in 2004 and headquartered in Florida, the company provides a comprehensive "Shoe Program" designed to help podiatrists dispense therapeutic footwear and custom-molded inserts to patients with diabetes. Their offerings include a wide selection of Medicare-approved shoes and high-quality orthotics produced in their own manufacturing laboratory. In April 2022, Dia-Foot was acquired by Orthotic Holdings (OHI), a global leader in lower-extremity orthotic solutions. The company plays a critical role in the preventative care cycle for diabetic patients, aiming to reduce the risk of foot ulcers and lower-limb amputations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DIA-FOOT.